医药之梯,一个专业的医药人才招聘网站!
, 欢迎您!

浙江伊普诺康生物技术有限公司

  

行业:医疗设备.器械 规模:50-99人 规模:私营/民营企业

      伊普诺康司是一家集研发、生产、销售、服务为一体的***高新技术企业,自创司以来,一直致力于做精做专生化产业,不断完善自己的产业基地。公司现有注册产品76项,涵盖肝功能类、肾功能类、心肌标志物类、血脂类、糖代谢类、特种蛋白类、肿瘤类等品类。随着体外诊断市场的不断细分和发展,公司正快速向POCT、免疫诊断、分子诊断等领域进军。与此同时,公司自主研发的伊普诺康品牌生化仪即将投产。
      创新生物科技,增进人类福祉。公司本着“诚信立足,创新取胜,以人为本,共赢共荣”的经营理念,始终贯彻求真务实,精益求精的思想,新辟大型现代化厂房,建设高端试剂产业化基地,引进先进生产设备,以雄厚的技术力量为依托,以严格的生产管理和品质控制为基础,以领先的销售模式和完善的市场布局为保证,创立了一套科学有效的营销服务体系,为您提供最专业的服务。
      “行远必自逊,追求无止境”,2016年1月,公司完成“新三板”挂牌(股票代码:835852),标志着公司在引进战略资本做大做强的道路上迈出了实质性的步伐。伊普诺康将以“新三板”上市为契机,恒久不辍地助力体外诊断事业,为中国检验医学的发展贡献力量!
      AnhuiIprocombiotechnologyCo.,Ltd,(Iprocom)isastate-levelhigh-techenterprisewhichintegratesresearch,manufactureandmarketing.Wearecommittedtomakeourcompanymoresophisticatedandmoreprofessionalinbiochemistryindustry,andtoconstantlyperfectourownindustrialbase.Iprocomhas76registeredproductsuptonow.Theseproductsencompassawiderangeofmedicalusessuchasliverfunction,renalfunction,cardiacbio-markers,glycometabolism,specialproteinsandtumoretc.withthedevelopmentandsubdivisionofInVitro?Diagnosticsmarket,IprocomisspeedilycomingintothefieldofPOCT,immunologicdiagnosisandmoleculardiagnosis.Meanwhile,Iprocomself-developedbiochemicalanalyzerwillsoongointoproduction.
      Innovationinbiotechnologywillinevitablybenefitthewelfareofallhumanbeings.Iprocomstickstothemanagementideasof“honestyasfoothold,triumphwithinnovation,peoplecomesfirst”andispersistentwithpragmatismandthespiritofstrivingforperfection.Furthermore,wehavebuiltanumberoflarge-scalemodernizedplants,reinforcedourhigh-endindustrializedbaseforreagents,andintroducedadvancedproductionequipmentfromabroad.Wewillrelyonstrongtechnicalpower,basedonrigorousmanagementrulesandqualitycontrol,guaranteedbyadvancedsalesmodelsandperfectmarketlayout,foundingasetofscientificandeffectivemarketingservicesystem,inordertoprovidethemostprofessionalserviceforyou!
      “Modestyleadstoprogressandthereisnolimittoexploration”.January2016,ourcompanyhascompletedthe“Threenewboard”listing(Stockcode:835852),whichmarksanessentialstepforwardtobeingstrongerbydrawingonstrategiccapitals.WearegoingtotakethisopportunitytoconsistentlysupportourinvitrodiagnosticcauseandmakeourcontributiontothedevelopmentofChina’sdiagnosticmedicalscience.

展开全部

网站备案号:浙ICP备12009347号-3 浙公网安备 33010602000646号 人才服务许可证:330101000577号

版权所有 Copyright ©2010- Olinking.com All Rights Reserved.

反馈
建议